Davis Polk advised Morgan Stanley & Co. LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and RBC Capital Markets, LLC as joint book-running managers and representatives of the underwriters in connection with the $126.5 million U.S. initial public offering and concurrent Canadian new issue offering of 8,161,291 common shares of Performance Sports Group Ltd. (formerly, Bauer Performance Sports Ltd.) (including 1,064,516 common shares from the full exercise of the underwriters’ over-allotment option). The common stock is listed on the New York Stock Exchange and the Toronto Stock Exchange under the symbol “PSG.”
Gilbert + Tobin advises on the IPO of Healthscope Limited
Gilbert + Tobin is advising the Joint Lead Managers to the Healthscope IPO, Macquarie Capital (Australia) Limited, UBS AG (Australia Branch), CIMB Capital Markets (Australia) Ltd, Credit Suisse (Australia) Limited, Goldman Sachs Australia Pty Limited and Merrill Lynch Equities (Australia) Limited. The listing will give Healthscope an implied market capitalisation of $3.3 – $3.8 billion at the offer price, making this the largest IPO in Australia since QR National in 2010.
Tags: Gilbert, LLPKirkland & Ellis Represents Braas Monier and its Stakeholders in Connection with Refinancing, High-Yield Bond and IPO
Kirkland & Ellis International LLP represented Braas Monier Building Group SA and its stakeholders, including Apollo Management, TowerBrook Capital Partners and York Capital Management, in connection with Braas Monier’s recent refinancing and high-yield bond offering, and the initial public offering of the business on the Frankfurt Stock Exchange earlier this week. The partial listing raised €470 million (approx. $639 million) and valued Monier at €940 million (approx. $1.28 billion).
More >>
Herbert Smith Freehills advises Asaleo Care on new banking facilities and material contracts in connection with its IPO
Knobbe Medical Device Client Ulthera Acquired for $600 Million
Merz and Ulthera, Inc. announced on June 26, 2014 that they have entered a definitive merger agreement pursuant to which Merz will acquire Ulthera, Inc, a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications using its therapeutic ultrasound platform technology. Valued at up to $600 million in upfront cash and milestone payments, the acquisition is the largest in Merz’s history.
Tags: Knobbe MartensClifford Chance Advises on AA’s IPO
Leading international law firm Clifford Chance is advising AA plc (the UK’s leading roadside assistance provider) and its owner Acromas Holdings, on its IPO on the London Stock Exchange, which has raised £1.385billion.
Tags: Clifford Chance LLPCoStar Group’s Registered Common Stock Offering
Cravath represented the underwriters, led by J.P. Morgan Securities, Goldman, Sachs & Co., BofA Merrill Lynch and Citigroup, in connection with the US$552 million registered common stock offering of CoStar Group, Inc., a leading provider of information and analytic services to the commercial real estate industry in the United States and the United Kingdom. The shares were listed on the NASDAQ Global Select Market. The transaction closed on June 11, 2014.








